Effect of Olorinab on Gastrointestinal Transit in Patients With Irritable Bowel Syndrome

Condition:   Irritable Bowel Syndrome Interventions:   Drug: Olorinab;   Drug: Placebo Sponsor:   Arena Pharmaceuticals Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials